62 companies

Incyte

Market Cap: US$25.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$123.47

7D

2.0%

1Y

44.5%

Exelixis

Market Cap: US$13.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$53.12

7D

5.4%

1Y

40.3%

Orion Oyj

Market Cap: €11.0b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€79.10

7D

1.5%

1Y

13.6%

CSPC Innovation Pharmaceutical

Market Cap: CN¥60.1b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

New

300765

CN¥43.15

7D

0.9%

1Y

-12.1%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥52.4b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

688578

CN¥116.48

7D

-0.7%

1Y

29.0%

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥42.1b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

688336

CN¥46.98

7D

0.4%

1Y

26.5%

Abbott India

Market Cap: ₹561.0b

Operates as a pharmaceutical company in India.

500488

₹26,400.00

7D

-6.2%

1Y

-19.1%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹514.0b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹3,034.05

7D

15.8%

1Y

8.9%

3SBio

Market Cap: HK$41.6b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

1530

HK$16.69

7D

-5.3%

1Y

-45.2%

ACADIA Pharmaceuticals

Market Cap: US$5.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ACAD

US$30.18

7D

2.6%

1Y

20.9%

Ajanta Pharma

Market Cap: ₹462.0b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

AJANTPHARM

₹3,697.90

7D

4.4%

1Y

37.8%

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥32.4b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥122.54

7D

2.2%

1Y

15.7%

SK Biopharmaceuticals

Market Cap: ₩6.7t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩85,300.00

7D

-3.3%

1Y

-12.1%

Xiamen Amoytop Biotech

Market Cap: CN¥26.3b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥64.40

7D

8.5%

1Y

-25.0%

Sumitomo Pharma

Market Cap: JP¥605.8b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,350.50

7D

0.04%

1Y

-2.2%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€59.70

7D

3.3%

1Y

4.1%

Neuland Laboratories

Market Cap: ₹298.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹23,296.85

7D

3.5%

1Y

69.8%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.0b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

4015

ر.س142.40

7D

0.6%

1Y

-10.9%

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

CDNA

US$46.18

7D

-2.2%

1Y

299.1%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.3b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

300573

CN¥40.10

7D

-5.0%

1Y

-9.8%

ADMA Biologics

Market Cap: US$2.1b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$9.54

7D

-3.7%

1Y

-45.3%

HBM Holdings

Market Cap: HK$12.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$14.49

7D

-3.6%

1Y

25.8%

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

INVA

US$21.25

7D

2.4%

1Y

3.6%

CORONA Remedies

Market Cap: ₹129.7b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

CORONA

₹2,121.40

7D

-0.7%

1Y

n/a

MeiraGTx Holdings

Market Cap: US$1.3b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

New

MGTX

US$13.89

7D

7.2%

1Y

83.7%

ChemoMetec

Market Cap: DKK 8.2b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 485.00

7D

4.0%

1Y

-6.6%

BioGaia

Market Cap: SEK 11.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 115.00

7D

3.0%

1Y

20.7%

Oscotec

Market Cap: ₩1.5t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

A039200

₩38,100.00

7D

-1.8%

1Y

15.6%

Basilea Pharmaceutica

Market Cap: CHF 739.2m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

New

BSLN

CHF 62.50

7D

18.8%

1Y

32.1%

Soho Global Health

Market Cap: Rp15.0t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

SOHO

Rp1,185.00

7D

0.4%

1Y

63.4%

Zevra Therapeutics

Market Cap: US$684.7m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$11.57

7D

2.0%

1Y

28.5%

CorMedix

Market Cap: US$636.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$8.17

7D

15.1%

1Y

-39.6%

Q32 Bio

Market Cap: US$474.8m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

QTTB

US$15.29

7D

-0.8%

1Y

744.8%

Rafa Laboratories

Market Cap: ₪1.4b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

RAFA

₪14.48

7D

-1.7%

1Y

n/a

DHG Pharmaceutical

Market Cap: ₫12.3t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

DHG

₫93,800.00

7D

-1.9%

1Y

-8.0%

Onconic Therapeutics

Market Cap: ₩635.7b

Engages in the research and development of anti-cancer therapy in South Korea.

A476060

₩14,000.00

7D

-11.4%

1Y

127.6%

Page 1 of 2